Commentary
Nab-paclitaxel – Third-line chemotherapy in advanced gallbladder cancer
Volume 152 | Issue 5 | November 2020
Disclaimer:
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.